Company

About

4D Biomaterials

4D Biomaterials

Thane Road, Nottingham, NG90 6BH, GB

The market for polymeric biomaterials is growing quickly, but despite this growth, it is widely recognised in the industry that the ‘holy grail’ solution has not yet been developed. The ideal biomaterial for use in regenerative medicine must: be biocompatible; promote tissue regeneration; have non-toxic biodegradation, have mechanical properties suited to the host tissue and good handling properties in a clinical environment. Our people have developed a patented range of novel polymeric 3-D printing resin-inks that promise, uniquely, to meet all of the above requirements and offer important advantages over the next best alternatives. The polymers and their degradation products are non-toxic and their properties can be tuned to suit a wide range of tissue regeneration applications. These 3-D printable resin-inks will enable medical implants to be fitted to the exact shape and dimensional requirements of each patient, optimising outcomes in applications such as cancer treatment, degenerative spinal conditions and reconstructive surgery. Initial in-vitro and in-vivo testing has provided strong evidence of the anticipated biocompatibility and tissue regeneration properties that will enable multiple stakeholders in the health sector to benefit from improved treatment options for a range of life-changing conditions, not least the patients themselves.

Amber Therapeutics

Amber Therapeutics

242 Acklam Road, London, England W10 5YG, GB

Amber Therapeutics was founded in 2021 with a mission to develop and deliver breakthrough neuromodulation therapies that can fundamentally restore normal physiological function in women suffering with mixed urinary incontinence. The company's first therapy, Amber UI, is an intelligent closed-loop bioelectrical therapy for urge and mixed urinary incontinence. The startup has also acquired Bioinduction, a fellow U.K.-based company and the maker of the Picostim DyNeuMo platform.

Aurora Spine

Aurora Spine

Harrogate, United Kingdom

Aurora specializes in minimally invasive, regenerative technologies. It is our vision to be the leader in advanced spinal technologies which will impact lives worldwide. Based in Carlsbad, California we design, develop and manufacture quality spinal implants to be sold worldwide.

Carta Genomics

Carta Genomics

309 ballards lane, london, greater london, united kingdom

Carta provides advanced genomic testing for IVF. We help IVF parents predict their embryo's disease risk and health outcomes in advance, resulting in improved women's health and healthier babies.

Corin Group

Corin Group

the corinium centre, cirencester, gloucestershire, united kingdom

As a leader in orthopaedic innovation, Corin has pioneered a number of landmark developments since its foundation and is proud to have been able to improve the quality of life of thousands of patients around the world through these groundbreaking products. The company's talented and dedicated teams share a common commitment to deliver quality orthopaedic products and services to patients, surgeons and healthcare providers which exceed expectations and positively impact lives. With an increasingly active and demanding patient population, the need to provide state of the art conservative treatment pathways, in addition to more traditional interventions, has never been more important. Corin's product portfolio is designed to provide each patient with the optimal solution, utilising some of the most advanced technologies available in the world to enhance implant longevity and performance.

LivaNova

LivaNova

London, United Kingdom

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol "LIVN." LivaNova has approximately 2,900 employees worldwide. We are headquartered in London (UK) and maintain a presence in more than 100 countries. LivaNova is a worldwide leader in cardiopulmonary and neuromodulation, dedicated to creating meaningful products and therapies that transform lives each and every day.

Metallo Bio

Metallo Bio

Sheffield, South Yorkshire

MetalloBio are developing two novel antimicrobial leads to combat multi-drug resistant Gram-negative bacteria.

Rayner

Rayner

10 Dominion Way, Worthing, West Sussex BN14 8AQ, GB

Rayner manufactured the world's first IOL in 1949, and has remained at the forefront of innovation for over 70 years, focused on providing you and your patients with the best IOLs and ophthalmic solutions - always driven by science to improve patient outcomes and safety. Rayner is the only manufacturer of IOLs in the UK, with its state-of-the-art manufacturing plant and Global Headquarters on the South Coast of England. Rayner is a fast-paced and growing business with 500+ employees worldwide.

Re-Vana

Re-Vana

Belfast, United Kingdom

Re-Vana Therapeutics is a venture-backed, pioneering therapeutics and ocular drug delivery company developing innovative sustained-release biologics to treat serious retinal diseases. The company’s proprietary photo-crosslinked, biodegradable platform technologies, EyeLief®, EyeLief SD™ and OcuLief®, enable custom delivery of a wide range of therapeutic molecules. Numerous platform capabilities create a therapeutic continuum to expand treatment opportunities through both internal development and external, strategic collaborations. Re-Vana envisions a new industry standard for sustained delivery of biologics to the retina, creating transformative and differentiated treatments for physicians and significantly reducing patient treatment burden.

TTP

TTP

Melbourn, United Kingdom

At TTP we work with start-ups through to big corporates, across multiple sectors, to solve challenging problems steeped in technology. By combing passion and flexibility with a deep expertise in science, engineering, and design, we help our clients unlock opportunities and make brilliant things happen. We're independent, we're free-thinkers and we're agile to the core, and for over 35 years it's helped us find better solutions faster – time and time again. We take a multidisciplinary approach, and our teams are set up around the project needs, which means we can tackle your problem holistically from the start. What's more, we'll be on your side and work with you as one team, and we'll want the project to succeed as much as you do.